Caditraz 2.5 mg Tablet
  1. Home
  2. Pharma Products
  3. Cadila Pharmaceutical Ltd
  4. Caditraz 2.5 mg Tablet

Caditraz 2.5 mg Tablet

Caditraz 2.5 mg Tablet contains letrozole, an aromatase inhibitor used mainly to treat hormone-sensitive breast cancer in postmenopausal women. It is an oral tablet taken according to the treatment plan prescribed by a qualified healthcare professional. Letrozole lowers estrogen production, helping slow or stop the growth of certain breast cancer cells.

BUY NOW

Category

Caditraz 2.5 mg Tablet is used for hormone receptor-positive early breast cancer and advanced breast cancer in postmenopausal women. Letrozole inhibits the aromatase enzyme, reducing estrogen levels and limiting estrogen stimulation of cancer cells. The tablet is generally taken once daily, with or without food, as directed by the physician. Regular medical follow-up may be required to monitor treatment response and effects associated with long-term estrogen reduction.

Technical Specification

Specification Details
Active Ingredient Letrozole
Strength 2.5 mg
Dosage Form Tablet
Route of Administration Oral
Pack Size 10 Tablets
Manufacturer Cadila Pharmaceuticals Ltd

Product Also Known As

Caditraz 2.5 mg Tablet, Caditraz 2.5 Tablet, Caditraz Letrozole Tablet, Letrozole 2.5 mg Tablet, Letrozole Breast Cancer Tablet, Letrozole Aromatase Inhibitor Tablet